Ono Richard Dana
CIK: 0001595989
Primary company: Inhibitor Therapeutics, Inc. (INTI)
Ono Richard Dana is a corporate insider at Inhibitor Therapeutics, Inc. (INTI) filing SEC Form 4 transactions. 35 transactions across 2 companies, totaling $1,360 in purchases and $3,033 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
Lipocine Inc. LPCN | Award | 1,764 | $2.19 | $4K | 13,290 | 6/3/2026 Filed: 6/3/2026 | Filing → |
Lipocine Inc. LPCN | Award | 1,764 | $3.20 | $6K | 11,526 | 6/4/2025 Filed: 6/5/2025 | Filing → |
Lipocine Inc. LPCN | Award | 1,764 | $7.05 | $12K | 10,938 | 6/5/2024 Filed: 6/7/2024 | Filing → |
Lipocine Inc. LPCN | Award | 30,000 | $0.27 | $8K | 166,000 | 5/10/2023 Filed: 5/12/2023 | Filing → |
Lipocine Inc. LPCN | Purchase | 4,000 | $0.34 | $1K | 14,125 | 3/20/2023 Filed: 3/20/2023 | Filing → |
Lipocine Inc. LPCN | Award | 22,000 | $0.92 | $20K | 136,000 | 6/8/2022 Filed: 6/10/2022 | Filing → |
Lipocine Inc. LPCN | Award | 22,000 | $1.26 | $28K | 22,000 | 6/9/2021 Filed: 6/10/2021 | Filing → |
Inhibitor Therapeutics, Inc. INTI | Award | 754,839 | $0.00 | $0 | 754,839 | 12/22/2020 Filed: 12/28/2020 | Filing → |
Lipocine Inc. LPCN | Exercise | 5,250 | $0.00 | $0 | 5,250 | 12/16/2020 Filed: 12/17/2020 | Filing → |
Lipocine Inc. LPCN | Exercise | 5,250 | $0.00 | $0 | 10,125 | 12/16/2020 Filed: 12/17/2020 | Filing → |
Lipocine Inc. LPCN | Award | 22,000 | $0.96 | $21K | 22,000 | 6/10/2020 Filed: 6/10/2020 | Filing → |
Inhibitor Therapeutics, Inc. INTI | Award | 1,000,000 | $0.00 | $0 | 1,000,000 | 3/20/2020 Filed: 3/24/2020 | Filing → |
Lipocine Inc. LPCN | Award | 10,000 | $1.68 | $17K | 10,000 | 6/12/2019 Filed: 6/14/2019 | Filing → |
HedgePath Pharmaceuticals, Inc. HPPI | Award | 657,895 | $0.00 | $0 | 657,895 | 2/3/2019 Filed: 2/5/2019 | Filing → |
Lipocine Inc. LPCN | Award | 20,000 | $1.33 | $27K | 20,000 | 6/27/2018 Filed: 6/28/2018 | Filing → |
HedgePath Pharmaceuticals, Inc. HPPI | Award | 56,000 | $0.00 | $0 | 56,000 | 3/13/2018 Filed: 3/15/2018 | Filing → |
HedgePath Pharmaceuticals, Inc. HPPI | Award | 253,000 | $0.00 | $0 | 253,000 | 3/13/2018 Filed: 3/15/2018 | Filing → |
Lipocine Inc. LPCN | Exercise | 1,750 | $0.00 | $0 | 5,250 | 12/29/2017 Filed: 1/2/2018 | Filing → |
Lipocine Inc. LPCN | Sale | 875 | $3.47 | $3K | 4,875 | 12/29/2017 Filed: 1/2/2018 | Filing → |
Lipocine Inc. LPCN | Exercise | 1,750 | $0.00 | $0 | 5,750 | 12/29/2017 Filed: 1/2/2018 | Filing → |
Lipocine Inc.
LPCN
Type
Award
Shares
1,764
Price
$2.19
Value
$4K
Lipocine Inc.
LPCN
Type
Award
Shares
1,764
Price
$3.20
Value
$6K
Lipocine Inc.
LPCN
Type
Award
Shares
1,764
Price
$7.05
Value
$12K
Lipocine Inc.
LPCN
Type
Award
Shares
30,000
Price
$0.27
Value
$8K
Lipocine Inc.
LPCN
Type
Purchase
Shares
4,000
Price
$0.34
Value
$1K
Lipocine Inc.
LPCN
Type
Award
Shares
22,000
Price
$0.92
Value
$20K
Lipocine Inc.
LPCN
Type
Award
Shares
22,000
Price
$1.26
Value
$28K
Inhibitor Therapeutics, Inc.
INTI
Type
Award
Shares
754,839
Price
$0.00
Value
$0
Lipocine Inc.
LPCN
Type
Exercise
Shares
5,250
Price
$0.00
Value
$0
Lipocine Inc.
LPCN
Type
Exercise
Shares
5,250
Price
$0.00
Value
$0
Lipocine Inc.
LPCN
Type
Award
Shares
22,000
Price
$0.96
Value
$21K
Inhibitor Therapeutics, Inc.
INTI
Type
Award
Shares
1,000,000
Price
$0.00
Value
$0
Lipocine Inc.
LPCN
Type
Award
Shares
10,000
Price
$1.68
Value
$17K
HedgePath Pharmaceuticals, Inc.
HPPI
Type
Award
Shares
657,895
Price
$0.00
Value
$0
Lipocine Inc.
LPCN
Type
Award
Shares
20,000
Price
$1.33
Value
$27K
HedgePath Pharmaceuticals, Inc.
HPPI
Type
Award
Shares
56,000
Price
$0.00
Value
$0
HedgePath Pharmaceuticals, Inc.
HPPI
Type
Award
Shares
253,000
Price
$0.00
Value
$0
Lipocine Inc.
LPCN
Type
Exercise
Shares
1,750
Price
$0.00
Value
$0
Lipocine Inc.
LPCN
Type
Sale
Shares
875
Price
$3.47
Value
$3K
Lipocine Inc.
LPCN
Type
Exercise
Shares
1,750
Price
$0.00
Value
$0
AI Agent
Try asking...